Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meir Bialer

Showing results (41-50 of 152) with videos related to

Pageof 16
Sort By:
CNS Drugs|May 8, 2002
Pros and cons for the development of new antiepileptic drugsMeir Bialer, Matthew C Walker, Josemir W Sander
Epilepsy & Behavior : E&B|December 8, 2004
Correlation analysis between anticonvulsant ED50 values of antiepileptic drugs in mice and rats and their therapeutic doses and plasma levelsMeir Bialer, Roy E Twyman, H Steve White
Epilepsia|January 11, 2021
Bioequivalence and switchability of generic antiseizure medications (ASMs): A re-appraisal based on analysis of generic ASM products approved in EuropeReem Odi, Valentina Franco, Emilio Perucca, et al.
Clinical Pharmacokinetics|August 14, 2020
The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral FormulationsValentina Franco, Pavel Gershkovich, Emilio Perucca, et al.
Epilepsia|July 3, 2020
A perspective on the physicochemical and biopharmaceutic properties of marketed antiseizure drugs-From phenobarbital to cenobamate and beyondReem Odi, David Bibi, Travis Wager, et al.
Epilepsia|November 23, 2006
Pharmacokinetics of the new antiepileptic and CNS drug RWJ-333369 following single and multiple dosing to humansCaiping Yao, Dennis R Doose, Gerald Novak, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|March 31, 2005
Identification of early-responsive genes correlated to valproic acid-induced neural tube defects in miceAkinobu Okada, Kiyoshi Kushima, Yoshinobu Aoki, et al.
Molecular Diagnosis & Therapy|November 24, 2016
Quantitative Assessment of CYP2C9 Genetic Polymorphisms Effect on the Oral Clearance of S-Warfarin in Healthy SubjectsChanan Shaul, Simcha Blotnick, Mordechai Muszkat, et al.
Epilepsia|March 30, 2023
Comparative activity of the enantiomers of fenfluramine and norfenfluramine in rodent seizure models, and relationship with their concentrations in plasma and brainNatalia Erenburg, Roa'a Hamed, Chanan Shaul, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|March 3, 2004
Amidic modification of valproic acid reduces skeletal teratogenicity in miceAkinobu Okada, Hiroshi Kurihara, Yoshinobu Aoki, et al.
Pageof 16

Showing results (41-50 of 152) with videos related to

Sort By:
Pageof 16
CNS Drugs|May 8, 2002
Pros and cons for the development of new antiepileptic drugsMeir Bialer, Matthew C Walker, Josemir W Sander
Epilepsy & Behavior : E&B|December 8, 2004
Correlation analysis between anticonvulsant ED50 values of antiepileptic drugs in mice and rats and their therapeutic doses and plasma levelsMeir Bialer, Roy E Twyman, H Steve White
Epilepsia|January 11, 2021
Bioequivalence and switchability of generic antiseizure medications (ASMs): A re-appraisal based on analysis of generic ASM products approved in EuropeReem Odi, Valentina Franco, Emilio Perucca, et al.
Clinical Pharmacokinetics|August 14, 2020
The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral FormulationsValentina Franco, Pavel Gershkovich, Emilio Perucca, et al.
Epilepsia|July 3, 2020
A perspective on the physicochemical and biopharmaceutic properties of marketed antiseizure drugs-From phenobarbital to cenobamate and beyondReem Odi, David Bibi, Travis Wager, et al.
Epilepsia|November 23, 2006
Pharmacokinetics of the new antiepileptic and CNS drug RWJ-333369 following single and multiple dosing to humansCaiping Yao, Dennis R Doose, Gerald Novak, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|March 31, 2005
Identification of early-responsive genes correlated to valproic acid-induced neural tube defects in miceAkinobu Okada, Kiyoshi Kushima, Yoshinobu Aoki, et al.
Molecular Diagnosis & Therapy|November 24, 2016
Quantitative Assessment of CYP2C9 Genetic Polymorphisms Effect on the Oral Clearance of S-Warfarin in Healthy SubjectsChanan Shaul, Simcha Blotnick, Mordechai Muszkat, et al.
Epilepsia|March 30, 2023
Comparative activity of the enantiomers of fenfluramine and norfenfluramine in rodent seizure models, and relationship with their concentrations in plasma and brainNatalia Erenburg, Roa'a Hamed, Chanan Shaul, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|March 3, 2004
Amidic modification of valproic acid reduces skeletal teratogenicity in miceAkinobu Okada, Hiroshi Kurihara, Yoshinobu Aoki, et al.
Pageof 16